Jazz Pharma Plc (JAZZ)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
110.80 +1.82 (+1.67%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 110.80 unch (unch) 16:27 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 560,120 | 414,832 | -224,060 | -329,668 | 238,616 |
| Depreciation Amortization | 660,067 | 638,696 | 629,471 | 552,483 | 278,253 |
| Income taxes - deferred | -208,327 | -260,217 | -292,251 | 69,198 | -136,937 |
| Accounts receivable | -21,115 | -51,883 | -90,135 | -92,735 | -38,647 |
| Accounts payable and accrued liabilities | -20,073 | 9,603 | -11,225 | 57,021 | -18,935 |
| Other Working Capital | -76,720 | -204,439 | 9,905 | -47,952 | -85,437 |
| Other Operating Activity | 501,956 | 545,415 | 1,250,272 | 570,160 | 662,735 |
| Operating Cash Flow | $1,395,908 | $1,092,007 | $1,271,977 | $778,507 | $899,648 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -460,125 | -120,100 | -1,036 | 1,068,181 | -642,675 |
| PPE Investments | -38,070 | -23,962 | -29,046 | -27,641 | -15,004 |
| Net Acquisitions | N/A | N/A | 53,000 | -6,234,792 | 14,259 |
| Purchase Sale Intangibles | -10,000 | -19,000 | -469,148 | -17,891 | -364,250 |
| Other Investing Activity | -10,000 | -19,000 | -469,148 | -17,891 | -364,250 |
| Investing Cash Flow | $-508,195 | $-163,062 | $-446,230 | $-5,212,143 | $-1,007,670 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 980,767 | N/A | N/A | 5,191,463 | 1,481,381 |
| Debt Repayment | -606,000 | -31,000 | -582,014 | -1,320,600 | -889,575 |
| Common Stock Issued | 20,647 | 46,459 | 98,020 | 135,261 | 99,681 |
| Common Stock Repurchased | -311,429 | -269,761 | -54 | 0 | -146,537 |
| Other Financing Activity | -63,469 | -50,952 | -45,443 | -35,602 | -16,877 |
| Financing Cash Flow | $20,516 | $-305,254 | $-529,491 | $3,970,522 | $528,073 |
| Exchange Rate Effect | -1,675 | 1,137 | -6,222 | -3,207 | 374 |
| Beginning Cash Position | 1,506,310 | 881,482 | 591,448 | 1,057,769 | 637,344 |
| End Cash Position | 2,412,864 | 1,506,310 | 881,482 | 591,448 | 1,057,769 |
| Net Cash Flow | $906,554 | $624,828 | $290,034 | $-466,321 | $420,425 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,395,908 | 1,092,007 | 1,271,977 | 778,507 | 899,648 |
| Capital Expenditure | -38,070 | -23,962 | -29,046 | -27,641 | -15,004 |
| Free Cash Flow | 1,357,838 | 1,068,045 | 1,242,931 | 750,866 | 884,644 |